Clinical and correlative results of a phase 1 study of cerdulatinib (PRT062070) a dual SYK/JAK inhibitor in patients with relapsed/refractory B cell malignancies Meeting Abstract
| Authors: | Hamlin, P. A.; Flinn, I.; Wagner-Johnston, N.; Burger, J. A.; Michelson, G.; Pandey, A.; Birrell, M.; Coffey, G. P.; Leeds, J. M.; Curnutte, J. T.; Patel, M. R. |
| Abstract Title: | Clinical and correlative results of a phase 1 study of cerdulatinib (PRT062070) a dual SYK/JAK inhibitor in patients with relapsed/refractory B cell malignancies |
| Meeting Title: | 57th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 126 |
| Issue: | 23 |
| Meeting Dates: | 2015 Dec 5-8 |
| Meeting Location: | Orlando, FL |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2015-12-03 |
| Language: | English |
| ACCESSION: | WOS:000368021800186 |
| PROVIDER: | wos |
| DOI: | 10.1182/blood.V126.23.3929.3929 |
| Notes: | Meeting Abstract: 3929 -- 57th Annual Meeting of the American-Society-of-Hematology -- DEC 05-08, 2015 -- Orlando, FL -- Source: Wos |
